Comparative Analysis of SARS-CoV-2 Reproduction Rates in the Dialysis and General Populations.
作者信息
Cherif Alhaji, Willetts Joanna L, Usvyat Len, Wang Yuedong, Kotanko Peter
机构信息
Renal Research Institute, Research Division, New York, New York.
Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.
出版信息
J Am Soc Nephrol. 2021 Apr;32(4):791-794. doi: 10.1681/ASN.2020121691. Epub 2021 Mar 8.
Abstract
摘要
相似文献
1
Comparative Analysis of SARS-CoV-2 Reproduction Rates in the Dialysis and General Populations.透析人群与普通人群中新冠病毒繁殖率的比较分析
J Am Soc Nephrol. 2021 Apr;32(4):791-794. doi: 10.1681/ASN.2020121691. Epub 2021 Mar 8.
2
COVID-19: mortality rates of patients on hemodialysis and peritoneal dialysis.COVID-19：血液透析和腹膜透析患者的死亡率。
Int Urol Nephrol. 2022 Oct;54(10):2713-2718. doi: 10.1007/s11255-022-03193-6. Epub 2022 Apr 5.
3
Long-Term Hemodialysis during the COVID-19 Pandemic.新冠疫情期间的长期血液透析
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1073-1074. doi: 10.2215/CJN.09100620. Epub 2020 Jul 2.
4
Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective.为何以及如何应在 2019 冠状病毒病大流行期间和之后提倡终末期肾病患者进行家庭透析？法国的观点。
J Nephrol. 2021 Aug;34(4):985-989. doi: 10.1007/s40620-021-01061-7. Epub 2021 Jun 1.
5
Confirmed Drop in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.2019年新型冠状病毒病大流行期间确诊的终末期肾病患者治疗量下降
J Am Soc Nephrol. 2022 Feb;33(2):455. doi: 10.1681/ASN.2021101296.
6
High Plasma Levels of Fibroblast Growth Factor 23 Are Associated with Increased Risk of COVID-19 in End-Stage Renal Disease Patients on Hemodialysis: Results of a Prospective Cohort.高血浆成纤维细胞生长因子 23 水平与血液透析终末期肾病患者 COVID-19 风险增加相关：一项前瞻性队列研究结果。
Toxins (Basel). 2023 Jan 19;15(2):97. doi: 10.3390/toxins15020097.
7
Going to war with COVID-19: Strategies for SARS-CoV-2 management in the Padua Nephrology and Dialysis Unit's hemodialysis facility.与新冠病毒作战：帕多瓦肾脏病与透析科血液透析设施中新冠病毒管理策略
Clin Nephrol. 2021 Mar;95(3):151-156. doi: 10.5414/CN110330.
8
How Hemodialysis Patients Perceive the SARS-CoV-2 Health Crisis: Lessons from Austria.血液透析患者如何看待 SARS-CoV-2 健康危机：来自奥地利的经验教训。
Kidney360. 2020 Aug 25;1(10):1077-1082. doi: 10.34067/KID.0003582020. eCollection 2020 Oct 29.
9
Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine.血液透析、腹膜透析和接受 BNT162b2 辉瑞-生物科技 SARS-CoV-2 疫苗免疫的肾移植患者的局部和全身免疫受损。
Front Immunol. 2022 Jul 22;13:832924. doi: 10.3389/fimmu.2022.832924. eCollection 2022.
10
Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis.奈玛特韦和利托那韦在终末期肾病行间歇性血液透析的 COVID-19 患者中的药代动力学。
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0122922. doi: 10.1128/aac.01229-22. Epub 2022 Oct 26.
引用本文的文献
1
Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-CoV-2 in End-Stage Renal Disease Patients on Chronic Hemodialysis: A Single-Center Study.替沙格韦单抗和西加韦单抗（埃武利尤单抗）增强慢性血液透析终末期肾病患者对 SARS-CoV-2 的抗体水平：一项单中心研究。
Medicina (Kaunas). 2023 Dec 1;59(12):2109. doi: 10.3390/medicina59122109.
2
COVID-19 Vaccination Trends and Side Effects among Egyptian Hemodialysis Patients: A Multicenter Survey Study.埃及血液透析患者中的新冠疫苗接种趋势及副作用：一项多中心调查研究
Vaccines (Basel). 2022 Oct 21;10(10):1771. doi: 10.3390/vaccines10101771.
3
Dynamics of spreading of SARS-CoV-2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains.SARS-CoV-2 在比利时血液透析中心传播的动力学：病毒株分析的重要性。
J Med Virol. 2022 Apr;94(4):1481-1487. doi: 10.1002/jmv.27471. Epub 2021 Nov 30.
4
Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study.塞内加尔血液透析患者中 SARS-CoV-2 抗体的流行情况：一项多中心横断面研究。
BMC Nephrol. 2021 Nov 17;22(1):384. doi: 10.1186/s12882-021-02582-w.
Zotero 插件